- Home
- SANG vs SGHT Comparison
SANG vs SGHT Comparison
Compare SANG & SGHT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SANG
- SGHT
- Stock Information
- Founded
- SANG 1984
- SGHT 2011
- Country
- SANG Canada
- SGHT United States
- Employees
- SANG N/A
- SGHT N/A
- Industry
- SANG Computer Software: Programming Data Processing
- SGHT Medical Specialities
- Sector
- SANG Technology
- SGHT Health Care
- Exchange
- SANG Nasdaq
- SGHT Nasdaq
- Market Cap
- SANG 153.5M
- SGHT 140.1M
- IPO Year
- SANG 2021
- SGHT 2021
- Fundamental
- Price
- SANG $5.90
- SGHT $3.03
- Analyst Decision
- SANG
- SGHT Buy
- Analyst Count
- SANG 0
- SGHT 7
- Target Price
- SANG N/A
- SGHT $3.92
- AVG Volume (30 Days)
- SANG 3.7K
- SGHT 161.2K
- Earning Date
- SANG 05-08-2025
- SGHT 05-08-2025
- Dividend Yield
- SANG N/A
- SGHT N/A
- EPS Growth
- SANG N/A
- SGHT N/A
- EPS
- SANG N/A
- SGHT N/A
- Revenue
- SANG $241,243,000.00
- SGHT $78,109,000.00
- Revenue This Year
- SANG N/A
- SGHT N/A
- Revenue Next Year
- SANG $2.91
- SGHT $11.17
- P/E Ratio
- SANG N/A
- SGHT N/A
- Revenue Growth
- SANG N/A
- SGHT N/A
- 52 Week Low
- SANG $4.08
- SGHT $2.03
- 52 Week High
- SANG $7.99
- SGHT $8.45
- Technical
- Relative Strength Index (RSI)
- SANG 67.39
- SGHT 56.13
- Support Level
- SANG $5.67
- SGHT $2.81
- Resistance Level
- SANG $5.97
- SGHT $3.26
- Average True Range (ATR)
- SANG 0.13
- SGHT 0.24
- MACD
- SANG 0.06
- SGHT -0.01
- Stochastic Oscillator
- SANG 95.04
- SGHT 38.57
About SANG Sangoma Technologies Corporation
Sangoma Technologies Corp is a provider of hardware and software components that enable or enhance Internet Protocol Communications Systems for both telecom and datacom applications. It is engaged in the development, manufacturing, distribution, and support of voice and data connectivity components for software-based communication applications. Its product includes data and telecom boards for media and signal processing, as well as gateway appliances and software. The Company sells into two geographic centers: USA and Other countries. Key revenue is generated from USA.
About SGHT Sight Sciences Inc.
Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. Its Surgical Glaucoma segment's product portfolio features the OMNI Surgical System, a device that facilitates the performance of both canaloplasty and trabeculotomy with a single device and single corneal incision to reduce intraocular pressure in adult patients with primary open-angle glaucoma. The company's Dry Eye segment's product portfolio consists of the TearCare System for ophthalmologists and optometrists. It derives key revenue from the Surgical Glaucoma segment.